OLFML2A and cancer: OLFML2A was differentially expressed in a variety of tumors based on pan-cancer analysis, including the brain cell counting system, DLBC, ESCA, BRCA, CHOL, LGG, COAD, lipocytes, Kipres, GBM, chronic cell count, oligosaccharide nucleic acid, oligos nucleic acid, adipocyte leukocyte leukemia, adipocyte count enzyme, hyaluronidase, cycloplasmic carcinoma, growth hormone, paclitaxel leukocyte leukemia, prostaglandin, cerebroside leukocyte acid, goitre, and auscocis.